1970
DOI: 10.1016/s0040-8166(70)80030-1
|View full text |Cite
|
Sign up to set email alerts
|

Release of dopamine β-hydroxylase and chromogranin A upon stimulation of the splenic nerve

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
46
0

Year Published

1976
1976
2009
2009

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 175 publications
(49 citation statements)
references
References 55 publications
3
46
0
Order By: Relevance
“…In vascular tissues, electrical stimulation of perivascular adrenergic nerves releases many substances, together with NA. They involve adenosine triphosphate (ATP), dopamine /3-hydroxylase, or metabolites of NA (SMITH et a!.,1970;Su,1975;KLEIN et a!.,1982;MISHIMA et al, 1984). Among these substances, ATP depolarizes vascular smooth muscle cells and decreases the membrane resistance (SuzuKi, 1985).…”
Section: Discussionmentioning
confidence: 99%
“…In vascular tissues, electrical stimulation of perivascular adrenergic nerves releases many substances, together with NA. They involve adenosine triphosphate (ATP), dopamine /3-hydroxylase, or metabolites of NA (SMITH et a!.,1970;Su,1975;KLEIN et a!.,1982;MISHIMA et al, 1984). Among these substances, ATP depolarizes vascular smooth muscle cells and decreases the membrane resistance (SuzuKi, 1985).…”
Section: Discussionmentioning
confidence: 99%
“…The enzyme dopamine -hydroxylase is found in noradrenergic neurons, and is released into synapses at the same time as the catecholamines (Smith, de Potter, Moerman & de Scaepdryver, 1970) where it catalyses the conversion of dopamine to noradrenaline (Kaufman & Friedman, 1965). DH therefore plays a critical role in controlling the balance of dopamine and noradrenaline available in the cortex.…”
Section: Introductionmentioning
confidence: 99%
“…Yet, although it is clear that different CGA storage granules may exhibit different cleavage patterns [4,5], very few data are available on CGA breakdown in sympathetic nerve axons [2,14] and almost none in nerve terminals, presumably because of difficulties in obtaining the appropriate vesicle preparations [16]. Moreover, while the release of CGA from sympathetic neurons has already been demonstrated [17,19], no evidence has yet been provided for the release of CGA 9roducts from adrenergic nerve terminals. Since the functional significance of CGA-derived peptide~ is a growing field of interest we have studied CGA breakdown in sympathetic neurons by comparing CGA immunoreactivity (CGA-IR) in preparations of LDYs from ox and dog sympathetic ganglia, splenic nerve and spleen, representing adrenergic cell bodies, axons and nerve terminals, respectively.…”
Section: Introductionmentioning
confidence: 99%